Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -11.16%1.1B | -24.33%233.56M | 264.3M | 306.67M | 10.96%1.24B | 5.12%308.67M | 6.71%1.12B | 293.65M | -8.13%1.05B | 1.14B |
| Cost of revenue | -14.28%722.1M | -35.16%130.95M | 179.5M | 207.34M | 12.84%842.38M | 0.47%201.95M | 12.87%746.53M | 201M | -10.46%661.44M | 738.74M |
| Gross profit | -4.52%378.71M | -3.85%102.61M | 84.8M | 99.33M | 7.17%396.66M | 15.19%106.72M | -3.87%370.12M | 92.65M | -3.83%385.01M | 400.34M |
| Operating expense | -9.87%151.59M | -21.21%41.17M | 33.02M | 39.59M | 17.49%168.19M | 20.62%52.25M | -46.71%143.16M | 43.32M | 168.06%268.67M | 100.23M |
| Staff costs | ---- | ---- | ---- | ---- | ---- | ---- | -76.11%41.4M | --10.55M | 545.74%173.3M | --26.84M |
| Selling and administrative expenses | -9.87%151.59M | -63.01%41.17M | --33.02M | --39.59M | 140.59%168.19M | 363.66%111.31M | -3.27%69.91M | --24.01M | 35.87%72.27M | --53.2M |
| -Selling and marketing expense | -20.16%75.32M | -64.01%19.66M | --17.55M | --18.07M | 67.87%94.34M | 173.65%54.62M | -3.43%56.2M | --19.96M | 31.84%58.2M | --44.14M |
| -General and administrative expense | 3.28%76.28M | -62.06%21.51M | --15.47M | --21.52M | 438.67%73.85M | 1,300.52%56.69M | -2.62%13.71M | --4.05M | 55.48%14.08M | --9.06M |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | 68.86%18.49M | --5.34M | 23.41%10.95M | --8.87M |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | 75.76%17.5M | --5.09M | 22.50%9.95M | --8.13M |
| -Amortization | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%997K | --249K | 33.29%997K | --748K |
| Rent and land expenses | ---- | ---- | ---- | ---- | ---- | ---- | 6.07%11.99M | --3.02M | 9.18%11.3M | --10.35M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | 41.24%1.75M | --531K | -3.95%1.24M | --1.29M |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | ---- | -6.42%379K | --122K | 25.00%405K | --324K |
| Operating profit | -0.59%227.11M | 12.81%61.44M | 51.78M | 59.74M | 0.66%228.46M | 10.42%54.47M | 95.08%226.96M | 49.33M | -61.23%116.34M | 300.11M |
| Net non-operating interest income (expenses) | -6.59%-19.08M | 76.66%-1.25M | -4.56M | -1.67M | 13.93%-17.9M | -76.75%-5.34M | -21.46%-20.8M | -3.02M | 23.70%-17.12M | -22.44M |
| Non-operating interest income | -35.33%1.6M | 635.47%3.21M | --465K | --4.4M | -9.78%2.47M | -35.16%437K | 10.76%2.74M | --674K | 51.07%2.47M | --1.64M |
| Non-operating interest expense | 1.50%20.68M | -22.77%4.46M | --5.02M | --6.07M | -13.44%20.37M | 56.33%5.78M | 20.11%23.54M | --3.69M | -18.61%19.6M | --24.08M |
| Net investment income | 30.93%7.08M | 136.92%5.41M | -216.38%-3.46M | 32.36%-14.64M | 2.97M | -34.04%-21.65M | -16.15M | |||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -51.52%-75.97M | 0.28%-13.55M | -29.38M | -20.5M | 8.81%-50.14M | -9.72%-13.58M | -47.35%-54.99M | -12.38M | -55.29%-37.32M | -24.03M |
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---5.39M |
| Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | ---- | 44.88%665K | --665K | --459K | --0 |
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | -109.82%-892K | --0 | 3.71%9.09M | --8.76M |
| Less:Write off | 51.52%75.97M | -4.11%13.55M | --29.38M | --20.5M | -9.19%50.14M | 20.57%14.13M | 98.81%55.21M | --11.72M | 34.42%27.77M | --20.66M |
| Other non-operating income (expenses) | -23.53%3.72M | -62.55%871K | 987K | 878K | 131.38%4.87M | 582.11%2.33M | -82.06%2.1M | 341K | -1.82%11.72M | 11.94M |
| Income before tax | -16.31%142.86M | 38.11%47.52M | 18.83M | 38.45M | 23.13%170.69M | -7.60%34.41M | 166.74%138.63M | 37.24M | -79.16%51.97M | 249.43M |
| Income tax | -11.08%37.65M | 17.70%11.47M | 5.35M | 11.06M | -18.20%42.34M | 2.84%9.75M | 3.70%51.76M | 9.48M | -20.76%49.92M | 62.99M |
| Net income | -18.03%105.21M | 46.17%36.05M | 13.48M | 27.39M | 47.76%128.35M | -11.16%24.67M | 4,127.20%86.87M | 27.76M | -98.90%2.06M | 186.44M |
| Net income continuous operations | -18.03%105.21M | 46.17%36.05M | --13.48M | --27.39M | 47.76%128.35M | -11.16%24.67M | 4,127.20%86.87M | --27.76M | -98.90%2.06M | --186.44M |
| Noncontrolling interests | 68.86%-161K | 33.00%-136K | -34K | 44K | -32.23%-517K | 23.40%-203K | -1.56%-391K | -265K | -49.22%-385K | -258K |
| Net income attributable to the company | -18.23%105.37M | 45.52%36.19M | 13.51M | 27.35M | 47.69%128.87M | -11.27%24.87M | 3,476.23%87.26M | 28.03M | -98.69%2.44M | 186.69M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -18.23%105.37M | 45.52%36.19M | 13.51M | 27.35M | 47.69%128.87M | -11.27%24.87M | 3,476.23%87.26M | 28.03M | -98.69%2.44M | 186.69M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -14.17%0.0772 | 45.77%0.0253 | 0.0094 | 0.0205 | 47.68%0.0899 | -11.28%0.0174 | 3,476.16%0.0609 | 0.0196 | -98.69%0.0017 | 0.1303 |
| Diluted earnings per share | -14.17%0.0772 | 45.77%0.0253 | 0.0094 | 0.0205 | 47.68%0.0899 | -11.28%0.0174 | 3,476.16%0.0609 | 0.0196 | -98.69%0.0017 | 0.1303 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.